콘텐츠로 건너뛰기
SOLUTIONS
Drug Discovery Sevices
Collaboration Partners
Platform
R&D
Platform Technology
Pipelines
Publications
Patent & Cert.
ABOUT US
Overview
History
Partnership
CI & BI
NEWS
Press Release
Seminars & Events
Notice
Responsibility
CAREER
Menu
SOLUTIONS
Drug Discovery Sevices
Collaboration Partners
Platform
R&D
Platform Technology
Pipelines
Publications
Patent & Cert.
ABOUT US
Overview
History
Partnership
CI & BI
NEWS
Press Release
Seminars & Events
Notice
Responsibility
CAREER
Get In Touch
PharmCADD accomplished funding and strategic alliances with Huons and other biopharmaceutical companies.
News
12/17/2020
<View Original Article>
Post Views:
118
Prev
Previous
PharmCADD’s mRNA vaccine candidate showed reliable immunogenicity in animal model
Next
PharmCADD will create an innovative AI drug and will be listed on KOSDAQ in March 2022.
Next